Background: Public demand and scrutiny, an aging population, inefficient funding and the legacy of Covid-19 are just some of the challenges the United Kingdom's health service faces. In imaging and oncology, there has been an exponential growth in service need against a workforce which is struggling to recruit and retain. This project aims to explore what the current, and future, workforce perceive the main opportunities and solutions, threats and risks are.

Method: Very short structured 'soundbite' interviews were employed to capture brief opinions or 'snippets' of dialogue. Participants recruited at a large imaging and oncology congress were asked what they considered the most significant opportunity/solution and threat/risk related to the future workforce. Descriptive and content analysis was undertaken to provide evaluation of role, regions, and frequency of themes.

Results: 88 'soundbite' interviews were undertaken lasting between 30 s and 4 min in length. The most common themes relating to opportunities/solutions considered education and students, workforce development and skill mix, and the use of technology. The most common threats/risks were identified as a lack of support for the workforce, recruitment and retention, national strategic issues, and barriers to workforce development.

Conclusion: The current workforce perceives a greater number of threats/risks for the future than potential opportunities/solutions. In particular, burnout and staff attrition were the most frequent perceptions of risk, though role development was often highlighted as the biggest opportunity. Interestingly AI and technology were frequently considered both opportunity and threat.

Implications For Practice: This study highlights that a lot needs to be done to support our future workforce and make best use of the potential opportunities and solutions.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radi.2024.10.017DOI Listing

Publication Analysis

Top Keywords

imaging oncology
12
'soundbite' interviews
12
future workforce
12
workforce
9
opportunities solutions
8
future
5
"making work
4
work face
4
face extreme
4
extreme adversity"
4

Similar Publications

Spatial mapping of the HCC landscape identifies unique intratumoral perivascular-immune neighborhoods.

Hepatol Commun

November 2024

Human Immunology Laboratory, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.

Background: HCC develops in the context of chronic inflammation; however, the opposing roles the immune system plays in both the development and control of tumors are not fully understood. Mapping immune cell interactions across the distinct tissue regions could provide greater insight into the role individual immune populations have within tumors.

Methods: A 39-parameter imaging mass cytometry panel was optimized with markers targeting immune cells, stromal cells, endothelial cells, hepatocytes, and tumor cells.

View Article and Find Full Text PDF

Neuropeptide Y in cancer-biological functions and potential clinical implications.

Cancer Metastasis Rev

January 2025

Department of Biochemistry and Molecular and Cellular Biology, Georgetown University Medical Center, BSB 231A, 3900 Reservoir Rd., NW, Washington, DC, 20057, USA.

Neuropeptide Y (NPY) is a sympathetic neurotransmitter widely distributed in the peripheral and central nervous system, affecting many physiological functions. Consequently, dysregulation of the NPY system contributes to numerous pathological disorders, including stress, obesity, and cancer. The pleiotropic functions of NPY in humans are mediated by G protein-coupled receptors (Y1R, Y2R, Y5R), which activate several signaling pathways and thereby regulate cell growth, differentiation, apoptosis, proliferation, angiogenesis, and metabolism.

View Article and Find Full Text PDF

Hyperprogressive disease induced by PD-1 inhibitor monotherapy in lung adenocarcinoma with HER2 exon 20 insertion: report of two cases and review of literature.

Discov Oncol

January 2025

Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republic of China.

Monotherapy with anti-programmed cell death protein 1 (PD-1) monoclonal antibody has been approved for the treatment of advanced non-small cell lung cancer with positive programmed cell death-ligand 1 (PD-L1) expression and oncogene wild type, which revealed survival benefit compared with chemotherapy. Nevertheless, certain patients develop rapid progression on anti-PD-1 inhibitor monotherapy. This novel pattern is called hyperprogressive disease (HPD), and the underlying mechanism and molecular characteristics still leaves not clear.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is a prevalent cancer that significantly contributes to mortality globally, primarily due to its late diagnosis. Early detection is crucial yet challenging. This study leverages the potential of deep learning (DL) technologies, employing the You Only Look Once (YOLO) architecture, to enhance the detection of HCC in computed tomography (CT) images, aiming to improve early diagnosis and thereby patient outcomes.

View Article and Find Full Text PDF

Background: The proportion and impact of minimal pleural effusion (PE) on prognosis remain blurred in operable non-small cell lung cancer (NSCLC) patients who reported minimal PE on imaging.

Methods: Clinical and prognostic data of operable NSCLC patients who presented no distant metastasis, no direct pleural invasion, but minimal PE on preoperative imaging were retrospectively analyzed. The patients were divided into surgical (81 cases) and non-surgical (10 cases) cohorts.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!